M.ST. EMERG. MKTS DEBT

COPENHAGEN, Denmark, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it has entered into an option and license agreement with MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) for two preclinical vaccine candidates. The agreement expands the companies' current collaboration and carries significant value for Evaxion. » Mehr auf globenewswire.com

NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/24 10/15/24     Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.22 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.135 The amount of net investment income to be paid by the Funds is determined in accordance with federal income tax regulatio. » Mehr auf businesswire.com

MS Emerging Markets Debt Fund offers a high yield of 11.44%, providing income-focused investors with significant current income and diversification from U.S. market risks. The MSD closed-end fund has outperformed benchmarks, delivering an 8.22% total return over three months, supported by favorable emerging market bond conditions and strategic trading. The fund's distribution is fully covered by net investment income, ensuring sustainability. » Mehr auf seekingalpha.com